Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3707)
All Articles published online
|
Feb 21, 2006 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i7/1125.htm |
| Number | Citing Articles |
| 1 |
Joseph R Volpicelli, Miriam Fenton. Sustained-Release Naltrexone Formulations for the Treatment of Alcohol and Opioid Dependence. Future Neurology 2006; 1(4): 389 doi: 10.2217/14796708.1.4.389
|
| 2 |
Babina Sanjel, Won-Sik Shim. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165958 doi: 10.1016/j.bbadis.2020.165958
|
| 3 |
GVMC Fernando, Nancy Preston. Refractory pruritus from malignant cholestasis: management. BMJ Supportive & Palliative Care 2023; 13(e1): e78 doi: 10.1136/bmjspcare-2019-002051
|
| 4 |
Sonja Ständer, Elke Weisshaar, Thomas A. Luger. Neurophysiological and neurochemical basis of modern pruritus treatment. Experimental Dermatology 2008; 17(3): 161 doi: 10.1111/j.1600-0625.2007.00664.x
|
| 5 |
Christopher Boehlke, Lisa Joos, Bettina Coune, Carola Becker, Joerg J Meerpohl, Sabine Buroh, Daniel Hercz, Guido Schwarzer, Gerhild Becker. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews 2024; 2024(8) doi: 10.1002/14651858.CD008320.pub4
|
| 6 |
Ana Marenco-Flores, Leandro Sierra, Daniela Goyes, Tamara Kahan, Vilas R. Patwardhan, Alan Bonder. Managing pruritus in chronic liver disease: An in-depth narrative review. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000187
|
| 7 |
Nora V. Bergasa. Research in the pruritus of cholestasis: Genetics, behavioral studies, and physiomimetic interorgan models. Medical Hypotheses 2022; 166: 110925 doi: 10.1016/j.mehy.2022.110925
|
| 8 |
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis. 2017; : 531 doi: 10.1007/978-3-319-33703-6_52
|
| 9 |
Mariusz Sikora, Adriana Rakowska, Małgorzata Olszewska, Lidia Rudnicka. The Use of Naltrexone in Dermatology. Current Evidence and Future Directions. Current Drug Targets 2019; 20(10): 1058 doi: 10.2174/1389450120666190318121122
|
| 10 |
Nora V. Bergasa. Update on the Treatment of the Pruritus of Cholestasis. Clinics in Liver Disease 2008; 12(1): 219 doi: 10.1016/j.cld.2007.11.009
|
| 11 |
Andreas E. Kremer, Ronald P.J. Oude Elferink, Ulrich Beuers. Pathophysiology and current management of pruritus in liver disease. Clinics and Research in Hepatology and Gastroenterology 2011; 35(2): 89 doi: 10.1016/j.clinre.2010.10.007
|
| 12 |
Nora V. Bergasa. Pruritus in Primary Biliary Cirrhosis: Pathogenesis and Therapy. Clinics in Liver Disease 2008; 12(2): 385 doi: 10.1016/j.cld.2008.02.013
|
| 13 |
Keith D. Lindor, Eric M. Gershwin, Raoul Poupon, Marshall Kaplan, Nora V. Bergasa, Jenny E. Heathcote. Primary biliary cirrhosis # †. Hepatology 2009; 50(1): 291 doi: 10.1002/hep.22906
|
| 14 |
Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal. AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis. Hepatology 2022; 76(3): 819 doi: 10.1002/hep.32378
|
| 15 |
Rami H. Mahmoud, Sarah G. Brooks, Gil Yosipovitch. Current and emerging drugs for the treatment of pruritus: an update of the literature. Expert Opinion on Pharmacotherapy 2024; 25(6): 655 doi: 10.1080/14656566.2024.2349193
|
| 16 |
Michele Pinon, Binita M. Kamath. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches. Current Opinion in Pediatrics 2024; 36(5): 524 doi: 10.1097/MOP.0000000000001380
|
| 17 |
Sarah Dillon, Joseph D. Tobias. Ondansetron to Treat Pruritus Due to Cholestatic Jaundice. The Journal of Pediatric Pharmacology and Therapeutics 2013; 18(3): 241 doi: 10.5863/1551-6776-18.3.241
|
| 18 |
Nora V. Bergasa. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Medical Hypotheses 2018; 110: 86 doi: 10.1016/j.mehy.2017.11.002
|
| 19 |
Parth Patel, Keshav Patel, Karan Pandher, Ruqiya Shama Tareen. The Role of Psychiatric, Analgesic, and Antiepileptic Medications in Chronic Pruritus. Cureus 2021; doi: 10.7759/cureus.17260
|
| 20 |
Joel E. Schlosburg, Dale L. Boger, Benjamin F. Cravatt, Aron H. Lichtman. Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus. Journal of Pharmacology and Experimental Therapeutics 2009; 329(1): 314 doi: 10.1124/jpet.108.150136
|
| 21 |
Atsuki Yamamoto, Shoji Kuyama, Chiaki Kamei, Yukio Sugimoto. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice. European Journal of Pharmacology 2010; 627(1-3): 162 doi: 10.1016/j.ejphar.2009.10.066
|
| 22 |
Tejesh Patel, Gil Yosipovitch. Therapy of pruritus. Expert Opinion on Pharmacotherapy 2010; 11(10): 1673 doi: 10.1517/14656566.2010.484420
|
| 23 |
Abhishek Gairola, Aaron Wetten, Jessica Dyson. Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis. Expert Opinion on Investigational Drugs 2024; 33(5): 485 doi: 10.1080/13543784.2024.2343789
|
| 24 |
Sonja Ständer, Thomas A. Luger. Therapy of Skin Diseases. 2010; : 235 doi: 10.1007/978-3-540-78814-0_24
|
| 25 |
Negar Faramarzi, Ata Abbasi, Seyed M Tavangar, Marjan Mazouchi, Ahmad R Dehpour. Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats. Journal of Gastroenterology and Hepatology 2009; 24(7): 1226 doi: 10.1111/j.1440-1746.2009.05794.x
|
| 26 |
Andreas E. Kremer. What are new treatment concepts in systemic itch?. Experimental Dermatology 2019; 28(12): 1485 doi: 10.1111/exd.14024
|
| 27 |
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis. 2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
|
| 28 |
Sombat Treeprasertsuk, Udomsak Silachamroon, Srivicha Krudsood, Arun Huntrup, Plengsakoon Suwannakudt, Suparp Vannaphan, Polrat Wilairatana. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice. Journal of Gastroenterology and Hepatology 2010; 25(2): 362 doi: 10.1111/j.1440-1746.2009.06007.x
|
| 29 |
Ngoc Quan Phan, Jeffrey D. Bernhard, Thomas A. Luger, Sonja Ständer. Antipruritic treatment with systemic μ-opioid receptor antagonists: A review. Journal of the American Academy of Dermatology 2010; 63(4): 680 doi: 10.1016/j.jaad.2009.08.052
|
| 30 |
Miriam M. Düll, Andreas E. Kremer. Evaluation and Management of Pruritus in Primary Biliary Cholangitis. Clinics in Liver Disease 2022; 26(4): 727 doi: 10.1016/j.cld.2022.06.009
|
| 31 |
Margit Baumann-Köhler, Almut Hartenstein-Pinter, Yvonne Hülsheger. Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. 2022; : 231 doi: 10.1007/978-3-662-63148-5_6
|
| 32 |
|
| 33 |
Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(7): 869 doi: 10.1016/j.bbadis.2014.02.007
|
| 34 |
Carolyn Stull, Michael J. Lavery, Gil Yosipovitch. Advances in therapeutic strategies for the treatment of pruritus. Expert Opinion on Pharmacotherapy 2016; 17(5): 671 doi: 10.1517/14656566.2016.1127355
|
| 35 |
Kimberly A. Bower, Gerit D. Mulder, Anke Reineke, Shireen V. Guide. Textbook of Interdisciplinary Pediatric Palliative Care. 2011; : 350 doi: 10.1016/B978-1-4377-0262-0.00035-9
|
| 36 |
Annabel Maruani, Mahtab Samimi, Gérard Lorette. Les prurigos. La Presse Médicale 2009; 38(7-8): 1099 doi: 10.1016/j.lpm.2008.10.014
|
| 37 |
Andreas Binder, Jana Koroschetz, Ralf Baron. Disease mechanisms in neuropathic itch. Nature Clinical Practice Neurology 2008; 4(6): 329 doi: 10.1038/ncpneuro0806
|
| 38 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pruritus in Chronic Cholestatic Liver Disease. Clinics in Liver Disease 2012; 16(2): 331 doi: 10.1016/j.cld.2012.03.010
|
| 39 |
Elliot B. Tapper, Nneka N. Ufere, Daniel Q. Huang, Rohit Loomba. Review article: current and emerging therapies for the management of cirrhosis and its complications. Alimentary Pharmacology & Therapeutics 2022; 55(9): 1099 doi: 10.1111/apt.16831
|
| 40 |
Juan Pablo Aristizábal Linares, Lester Andrade Almario. Eficacia de la naltrexona en el tratamiento de prurito severo. Revista Colombiana de Anestesiología 2011; 39(2): 251 doi: 10.5554/rca.v39i2.91
|
| 41 |
Charles Dervout, Nicholas Boulais, Thomas Barnetche, Jean-Baptiste Nousbaum, Emilie Brenaut, Laurent Misery. Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis. Acta Dermato-Venereologica 2022; 102: adv00653 doi: 10.2340/actadv.v102.310
|
| 42 |
Kazuto Tajiri, Yukihiro Shimizu. Recent advances in the management of pruritus in chronic liver diseases. World Journal of Gastroenterology 2017; 23(19): 3418-3426 doi: 10.3748/wjg.v23.i19.3418
|
| 43 |
Santiago Medina Ramírez, Ana Milena Sánchez, Francisco Gómez Oquendo. Sugammadex en un paciente con insuficiencia renal crónica. Revista Colombiana de Anestesiología 2011; 39(3): 433 doi: 10.5554/rca.v39i3.219
|
| 44 |
|
| 45 |
Konstantin Agelopoulos, Manuel Pedro Pereira, Henning Wiegmann, Sonja Ständer. Cutaneous neuroimmune crosstalk in pruritus. Trends in Molecular Medicine 2022; 28(6): 452 doi: 10.1016/j.molmed.2022.03.005
|
| 46 |
Emilie Javelle, Philippe Paule, Yves Chabrillat, Edward Lightburn, Thierry Coton, Jean-Jacques Morand. Un prurit traité par implantation d’un pacemaker. La Presse Médicale 2011; 40(9): 885 doi: 10.1016/j.lpm.2011.03.003
|
| 47 |
Carola Xander, Joerg J Meerpohl, Daniel Galandi, Sabine Buroh, Guido Schwarzer, Gerd Antes, Gerhild Becker, Carola Xander. Cochrane Database of Systematic Reviews. 2013; doi: 10.1002/14651858.CD008320.pub2
|
| 48 |
Nora V. Bergasa. Cirrhosis: A practical guide to management. 2015; : 291 doi: 10.1002/9781118412640.ch26
|
| 49 |
Andrea A. Gossard, Keith D. Lindor. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. 2010; : 87 doi: 10.1002/9781444325249.ch10
|
| 50 |
Puneeta Tandon, Brian H. Rowe, Ben Vandermeer, Vincent G. Bain. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus. The American Journal of Gastroenterology 2007; 102(7): 1528 doi: 10.1111/j.1572-0241.2007.01200.x
|
| 51 |
|
| 52 |
Hirsh D. Trivedi, Blanca Lizaola, Elliot B. Tapper, Alan Bonder. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review. The American Journal of Medicine 2017; 130(6): 744.e1 doi: 10.1016/j.amjmed.2017.01.037
|
| 53 |
Waldemar Siemens, Carola Xander, Joerg J Meerpohl, Sabine Buroh, Gerd Antes, Guido Schwarzer, Gerhild Becker. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews 2016; 2016(11) doi: 10.1002/14651858.CD008320.pub3
|
| 54 |
Stephani L. Stancil, Susan Abdel-Rahman, Jon Wagner. Developmental Considerations for the Use of Naltrexone in Children and Adolescents. The Journal of Pediatric Pharmacology and Therapeutics 2021; 26(7): 675 doi: 10.5863/1551-6776-26.7.675
|
| 55 |
Juan Trivella, Binu V. John, Cynthia Levy. Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000179
|
| 56 |
Kapil Vyas, Kriti Maheshwari, Praveen K. Shanmugam Reddy, Rajesh Verma, Iffat Hasan, Asit Mittal. Prescription Practices Regarding the use of Systemic Drugs in the Management of Patients with Chronic Pruritus amongst Indian Dermatologists – A Questionnaire Based Survey. Indian Dermatology Online Journal 2024; 15(1): 33 doi: 10.4103/idoj.idoj_500_22
|
| 57 |
F.J. Navarro-Triviño. [Translated article] Pruritus in Dermatology: Part 2—Diseases and Their Treatment. Actas Dermo-Sifiliográficas 2023; 114(7): T613 doi: 10.1016/j.ad.2023.06.007
|
| 58 |
Fatima Isa, Grace M. Turner, Geetinder Kaur, Derek Kyte, Anita Slade, Tanya Pankhurst, Larissa Kerecuk, Thomas Keeley, James Ferguson, Melanie Calvert. Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review. Health and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0951-6
|
| 59 |
|
| 60 |
Andreas E. Kremer, Ronald P. J. Oude-Elferink, Ulrich Beuers. Pruritus. 2010; : 177 doi: 10.1007/978-1-84882-322-8_28
|
| 61 |
Jacqueline A. G. M. Langedijk, Ulrich H. Beuers, Ronald P. J. Oude Elferink. Cholestasis-Associated Pruritus and Its Pruritogens. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.639674
|
| 62 |
Richard J. Bodnar. Endogenous opiates and behavior: 2006. Peptides 2007; 28(12): 2435 doi: 10.1016/j.peptides.2007.09.002
|
| 63 |
F.J. Navarro-Triviño. Prurito en dermatología. Enfermedades y su tratamiento. Parte 2. Actas Dermo-Sifiliográficas 2023; 114(7): 613 doi: 10.1016/j.ad.2023.03.004
|
| 64 |
Adhyatm Bhandari, Rahul Mahajan. Skin Changes in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1215 doi: 10.1016/j.jceh.2021.12.013
|
| 65 |
Ashley Vander Does, Cynthia Levy, Gil Yosipovitch. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments. American Journal of Clinical Dermatology 2022; 23(5): 647 doi: 10.1007/s40257-022-00710-2
|
| 66 |
Ahmad H. Ali, Elizabeth J. Carey, Keith D. Lindor. Liver Disorders. 2017; : 251 doi: 10.1007/978-3-319-30103-7_16
|
| 67 |
Fay Louise Murray-Brown. Naltrexone for cholestatic itch: a systematic review. BMJ Supportive & Palliative Care 2021; 11(2): 217 doi: 10.1136/bmjspcare-2020-002801
|
| 68 |
Elsemieke de Vries, Ruth Bolier, Jorn Goet, Albert Parés, Jef Verbeek, Marleen de Vree, Joost Drenth, Karel van Erpecum, Karin van Nieuwkerk, Frans van der Heide, Nahid Mostafavi, Jeltje Helder, Cyriel Ponsioen, Ronald Oude Elferink, Henk van Buuren, Ulrich Beuers. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial. Gastroenterology 2021; 160(3): 734 doi: 10.1053/j.gastro.2020.10.001
|
| 69 |
Vishwajit Kode, Kidist K. Yimam. Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging Therapies. Current Hepatology Reports 2024; 23(1): 123 doi: 10.1007/s11901-024-00638-7
|